During the past decade, Fondazione MBBM conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Fondazione MBBM" are "Acute Graft-versus-host Disease" (1 trials), "Acute Lymphoblastic Leukemia" (1 trials), "Arginase I Deficiency" (1 trials) and "Hyperargininemia" (1 trials). Many other conditions were trialed in "Fondazione MBBM" in a lesser frequency.

Most popular intervention types in "Fondazione MBBM" are "Drug" (2 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Corticosteroids" (1 trials), "Itacitinib" (1 trials), "PTG-CARCIK-CD19" (1 trials), "Pegzilarginase" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fondazione MBBM" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Fondazione MBBM". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Fondazione MBBM, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Fondazione MBBM, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Fondazione MBBM has several departments that took part in Clinical trials: "Fondazione MBBM-Clinica Pediatrica" - 2 trials